Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;335:414 (1 September), doi:10.1136/bmj.39317.508079.80
| The first 150 words of the full text of this article appear below. |
The study by Canani et al concluded that probiotics should be classified as drugs, and doctors should select preparations for which evidence of efficacy, in a given clinical condition, is supported by solid data.1
All nutritional supplements that are sold on the basis of their health promoting properties should be classified as drugs, and they should have to undergo the same rigorous process as pharmaceutical drugs to establish their efficacy and safety before they are placed on the market. The global market for probiotics and supplements continues to grow, and a growing number of "nutritionists" and nutritional supplements are trying to cash in. Consumers deserve to have accurate information about the efficacy and potential side effects of these products in the same way that they do for other over the counter drugs. If these substances were classified as drugs, doctors could then prescribe them on the NHS for their specific
Paula J Whittaker, specialist registrar, public health
Greater Manchester Health Protection Unit, Manchester M30 0NJ
paula.whittaker@gmhpu.nhs.uk
UK medical students have published unreleased government plans to restrict failed asylum seekers' access to medical care